Changchun BCHT Biotechnology Co., Ltd. (688276)

Overview

Changchun BCHT Biotechnology Co. Ltd. is a prominent biopharmaceutical firm rooted in the heart of China. With a foundation laid in 2004, the company has dedicated itself to the noble pursuit of safeguarding human health through the power of science. Operating both within China and on an international scale, Changchun BCHT specializes in a critical facet of medical care - vaccines. The company’s infrastructure is designed around the research and development, manufacturing, and distribution of innovative vaccine solutions aimed at combating various diseases.

Products and Services

Changchun BCHT Biotechnology Co. Ltd. offers a diversified portfolio of vaccine products, each developed with cutting-edge technology and the highest standards of safety and efficacy. This includes:

• Live Herpes Zoster Vaccine: This vaccine is designed to protect against shingles, a condition caused by the reactivation of the varicella-zoster virus in individuals who have previously had chickenpox.
• Live Varicella Vaccine: Aimed at preventing chickenpox, this vaccine is a crucial tool in controlling the spread of this common and highly contagious disease.
• Live, Nasal, and Freeze-Dried Influenza Vaccine: Offering a unique delivery method through the nasal passage, this influenza vaccine is designed for those seeking a needle-free option for flu prevention. The freeze-drying process ensures stability and longevity of the vaccine, making it more accessible, especially in regions with limited refrigeration facilities.
• Rabies vaccine (vero cell) for humans: This vaccine is an essential part of the prophylactic regimen for individuals at risk of rabies, a fatal disease transmitted through the saliva of infected animals. By using vero cells, the vaccine is cultured in a controlled environment, ensuring its purity and effectiveness.